| Code | 0385A | ||||||||||
| MA number | 44/0092/11-S | ||||||||||
| Product Form: | sol ijf 1x50 ml/2,5 g (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous and intraarterial use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 18.02.2011 |
| SPC: |
SPC_Fluorouracil Accord 50 mg_ml injekčný a infúzny roztok_03.2025.pdf
|
| PIL: |
PIL_Fluorouracil Accord 50 mg_ml injekčný a infúzny roztok_03.2025.pdf
|
| Safety feature | Yes |
| Data update: | 16.04.2019 |
